Bryan Reasons
President presso CADENCE PHARMACEUTICALS, INC.
Patrimonio netto: 29 849 $ in data 31/03/2024
Profilo
Bryan Marlen Reasons is currently the Chairman at Impax Laboratories (Taiwan), Inc. He is also an Independent Director at Aclaris Therapeutics, Inc., the President & Director at Mallinckrodt Hospital Products, Inc., a Director at MKG Medical UK Ltd., the Executive VP, Chief Financial & Accounting Officer at Mallinckrodt Plc, and the Chief Financial Officer & Executive Vice President at Mallinckrodt Pharmaceuticals Ltd.
In his former positions, Mr. Reasons served as an Independent Director at Societal CDMO, Inc. from 2017 to 2024.
He was the Vice President-Finance at Cephalon, Inc. from 2005 to 2011 and at Teva Pharmaceutical Industries Ltd.
from 2011 to 2012.
From 2012 to 2018, he held the position of Chief Financial Officer & Senior VP-Finance at Impax Laboratories LLC.
Prior to that, he worked as a Senior Manager at PricewaterhouseCoopers LLP from 1992 to 2003 and as the Vice President-Finance at DuPont de Nemours, Inc. from 2003 to 2005.
He also served as the Chief Financial Officer & Senior Vice President at Amneal Intermediate, Inc. from 2018 to 2019.
Mr. Reasons obtained his undergraduate degree from The Pennsylvania State University.
He also holds an MBA from Widener University, which he received in 1992.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 02/06/2023 | 24 072 ( 0.03% ) | 29 849 $ | 31/03/2024 | |
SOCIETAL CDMO, INC.
-.--% | 08/04/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Bryan Reasons
| Società | Posizione | Inizio |
|---|---|---|
| ACLARIS THERAPEUTICS, INC. | Director/Board Member | 24/04/2018 |
| MALLINCKRODT PLC | Director of Finance/CFO | 18/03/2019 |
| CADENCE PHARMACEUTICALS, INC. | President | - |
Mallinckrodt Pharmaceuticals Ltd.
 Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Mallinckrodt Plc, Mallinckrodt Pharmaceuticals Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The private company is based in Staines Upon Thames, UK and was founded in 2015. | Director of Finance/CFO | - |
Precedenti posizioni note di Bryan Reasons
| Società | Posizione | Fine |
|---|---|---|
| SOCIETAL CDMO, INC. | Director/Board Member | 08/04/2024 |
Amneal Intermediate, Inc.
 Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. | Director of Finance/CFO | 01/01/2019 |
| AMNEAL PHARMACEUTICALS, INC. | Director of Finance/CFO | 01/01/2019 |
Impax Laboratories LLC
 Impax Laboratories LLC Pharmaceuticals: MajorHealth Technology Impax Laboratories LLC operates as a technology based specialty pharmaceutical company. It engages in the development, manufacture, and marketing of controlled-release and niche generics. The company was founded on December 14, 1999 and is headquartered in Bridgewater, NJ. | Director of Finance/CFO | 01/05/2018 |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 01/01/2012 |
Formazione di Bryan Reasons
| Widener University | Masters Business Admin |
| The Pennsylvania State University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 5 |
|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
| ACLARIS THERAPEUTICS, INC. | Health Technology |
| MALLINCKRODT PLC | Health Technology |
| DUPONT DE NEMOURS, INC. | Process Industries |
| AMNEAL PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 7 |
|---|---|
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Health Technology |
Impax Laboratories LLC
Impax Laboratories LLC Pharmaceuticals: MajorHealth Technology Impax Laboratories LLC operates as a technology based specialty pharmaceutical company. It engages in the development, manufacture, and marketing of controlled-release and niche generics. The company was founded on December 14, 1999 and is headquartered in Bridgewater, NJ. | Health Technology |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
| Societal CDMO, Inc. | |
Amneal Intermediate, Inc.
Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. | Health Technology |
Mallinckrodt Pharmaceuticals Ltd.
Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Mallinckrodt Plc, Mallinckrodt Pharmaceuticals Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The private company is based in Staines Upon Thames, UK and was founded in 2015. | Health Technology |
Mallinckrodt Hospital Products, Inc.
 Mallinckrodt Hospital Products, Inc. Pharmaceuticals: MajorHealth Technology Mallinckrodt Hospital Products, Inc. operates as a biopharmaceutical company, which develops and commercializes proprietary product candidates used in the hospital setting. The firm offers OFIRMEV (acetaminophen injection), a proprietary intravenous formulation of acetaminophen for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics and the reduction of fever. The company was founded by Theodore R. Schroeder, David A. Socks, and Cam L. Garner on May 26, 2004 and is headquartered in Hazelwood, MO. | Health Technology |
- Borsa valori
- Insiders
- Bryan Reasons
